Results 281 to 290 of about 115,105 (360)

Combination of Oral Hydroxychloroquine and Topical Pimecrolimus 1% for Linear Morphea in Breastfeeding: A Rare Case with Favorable Outcome. [PDF]

Int J Womens Health
Suwarsa O, Hidayah RMN, Avriyanti E, Sutedja E, Pangastuti M, Firdaus CP, Achdiat PA, Pratama DG.   +7 more
europepmc   +1 more source

Early-onset bull’s eye maculopathy due to hydroxychloroquine in rheumatoid arthritis and myasthenia gravis [PDF]

Ali Kasiri, Ali Ansari, Ali Ansari, Rozhin Kasiri, Rozhin Kasiri, Abbas Mohammadi   +5 more
openalex   +1 more source

Regulatory mechanism of O‐linked N‐acetylglucosamine protein modification on autophagy in cancer

Clinical and Translational Medicine, Volume 16, Issue 1, January 2026.
O‐GlcNAcylation serves as a nutrient and stress sensor that dynamically regulates autophagy at multiple stages in cancer cells. It fine‐tunes autophagy initiation, maturation and fusion by modifying key proteins such as ULK1, ATG4B and SNAP‐29. Context‐dependent O‐GlcNAcylation promotes tumour adaptation and therapy resistance via autophagy remodelling.
Yizhan Li, Ling Gao, Shaoming Li, Jingjing Zheng, Keqian Zhi, Wenhao Ren   +5 more
wiley   +1 more source

Systemic Lupus Erythematosus: Ophthalmological Safety Considerations of Emerging and Conventional Therapeutic Agents. [PDF]

Int J Mol Sci
Luboń W, Luboń M, Agaś-Lange A, Dorecka M.   +3 more
europepmc   +1 more source

Is there sufficient scientific evidence to rule out the use of hydroxychloroquine for postexposure prophylaxis of COVID-19?

, 2020
Llorenç Quintó, José Miguel Morales‐Asencio, Raquel Sáez González, Clara Menéndez   +3 more
openalex   +2 more sources

Clinical Characteristics of Patients With Anti‐Signal Recognition Particle Antibody: A Cohort Study

Immunity, Inflammation and Disease, Volume 14, Issue 1, January 2026.
ABSTRACT Background Anti‐signal recognition particle (anti‐SRP) antibodies are myositis‐specific autoantibodies associated with immune‐mediated necrotizing myopathy. This study was undertaken to better understand how patients with anti‐SRP antibodies have been managed at our tertiary centre and to assess the spectrum of clinical features and outcomes ...
Ameen Jubber, Maumer Durrani, Abdullah Almayahi, Kehinde Sunmboye   +3 more
wiley   +1 more source

Associations between hydroxychloroquine dose and risk of flares in systemic lupus erythematosus. [PDF]

BMC Rheumatol
Zou Y, Peng Y, Zhong Y, Li SG, Zhao Z, Yao H.   +5 more
europepmc   +1 more source

Clinical Images: Co‐occurrence of Bywaters lesions and Jaccoud arthropathy in a patient

ACR Open Rheumatology, Volume 8, Issue 1, January 2026.
Hiu Laam Christy Sit, Allan Sturgess
wiley   +1 more source

Melanoma: Pathogenesis and Targeted Therapy

MedComm, Volume 7, Issue 1, January 2026.
The treatment landscape for advanced melanoma has evolved significantly. BRAF–MEK inhibitor combinations are standard for BRAF‐mutant melanoma, whereas targeting NRAS mutations is more challenging, with MEK inhibitors like tunlametinib emerging as an option.
Yang Fu, Jie Liu, Zeming Mo, Bin Wang, Yaotiao Deng, Yu Jiang   +5 more
wiley   +1 more source

Granulomatous filler reaction treated with adalimumab: a case report and literature review. [PDF]

An Bras Dermatol
Gamez-Siller P, Moreno-Davila H, Oscherwitz M, Franco-Marquez R, Galarza-Delgado DA, Cardenas-de la Garza JA.   +5 more
europepmc   +1 more source